{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:36:48Z","timestamp":1790692608133,"version":"4.1.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00210-024-03539-0","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:03:10Z","timestamp":1729580590000},"page":"2365-2386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7435-1861","authenticated-orcid":false,"given":"Marina","family":"Galicia-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8891-5317","authenticated-orcid":false,"given":"Hugo Christian","family":"Monroy-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4033-3814","authenticated-orcid":false,"given":"Fernando","family":"Caloca-Camarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-622X","authenticated-orcid":false,"given":"Scarlet","family":"Arceo-Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-6631","authenticated-orcid":false,"given":"Pablo","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1708-1495","authenticated-orcid":false,"given":"Ana","family":"Sandoval-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3430-9391","authenticated-orcid":false,"given":"Jes\u00fas","family":"Garc\u00eda-Ba\u00f1uelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-4641","authenticated-orcid":false,"given":"Alejandro","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3895-821X","authenticated-orcid":false,"given":"Jos\u00e9","family":"Navarro-Partida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7101-9943","authenticated-orcid":false,"given":"Juan","family":"Armendariz-Borunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"3539_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s12013-014-0031-4","volume":"70","author":"H Aksit","year":"2014","unstructured":"Aksit H, Bildik A (2014) Determination of DNA damage in experimental liver intoxication and role of N-acetyl cysteine. Cell Biochem Biophys 70:1119\u20131125. https:\/\/doi.org\/10.1007\/s12013-014-0031-4","journal-title":"Cell Biochem Biophys"},{"key":"3539_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mam.2007.09.004","volume":"29","author":"E Albano","year":"2008","unstructured":"Albano E (2008) Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 29:9\u201316. https:\/\/doi.org\/10.1016\/j.mam.2007.09.004","journal-title":"Mol Aspects Med"},{"key":"3539_CR3","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","volume":"52","author":"G Aldini","year":"2018","unstructured":"Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, Sergio F (2018) N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res 52:751\u2013762. https:\/\/doi.org\/10.1080\/10715762.2018.1468564","journal-title":"Free Radic Res"},{"key":"3539_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1615\/CritRevOncog.2020036027","volume":"26","author":"S Aliya","year":"2021","unstructured":"Aliya S (2021) Targeting key transcription factors in hepatocellular carcinoma. Crit Rev Oncog 26:51\u201360. https:\/\/doi.org\/10.1615\/CritRevOncog.2020036027","journal-title":"Crit Rev Oncog"},{"key":"3539_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.joen.2015.01.024","volume":"41","author":"A Aminoshariae","year":"2015","unstructured":"Aminoshariae A, Khan A (2015) Acetaminophen: old drug, new issues. J Endod 41:588\u2013593. https:\/\/doi.org\/10.1016\/j.joen.2015.01.024","journal-title":"J Endod"},{"key":"3539_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2019) Burden of liver diseases in the world. J Hepatol 70:151\u2013171. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014","journal-title":"J Hepatol"},{"key":"3539_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"KR Atkuri","year":"2007","unstructured":"Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA (2007) N-Acetylcysteine\u2014a safe antidote for cysteine\/glutathione deficiency. Curr Opin Pharmacol 7:355\u2013359. https:\/\/doi.org\/10.1016\/j.coph.2007.04.005","journal-title":"Curr Opin Pharmacol"},{"key":"3539_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0016-5085(03)00695-4","volume":"125","author":"R Bataller","year":"2003","unstructured":"Bataller R, Sancho-Bru P, Gin\u00e8s P, Lora JM, Al-garawi A, Sol\u00e9 M, Colmenero J, Nicol\u00e1s JM, Jim\u00e9nez W, Weich N, Guti\u00e9rrez-Ramos JC, Arroyo V, Rod\u00e9s J (2003) Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125:117\u2013125. https:\/\/doi.org\/10.1016\/s0016-5085(03)00695-4","journal-title":"Gastroenterology"},{"key":"3539_CR9","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/jn\/138.10.1872","volume":"138","author":"JN Baumgardner","year":"2008","unstructured":"Baumgardner JN, Shankar K, Hennings L, Albano E, Badger TM, Ronis MJ (2008) N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J Nutr 138:1872\u20131879. https:\/\/doi.org\/10.1093\/jn\/138.10.1872","journal-title":"J Nutr"},{"key":"3539_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jhep.2022.09.001","volume":"78","author":"C Berasain","year":"2023","unstructured":"Berasain C, Arechederra M, Argem\u00ed J, Fern\u00e1ndez-Barrena MG, Avila MA (2023) Loss of liver function in chronic liver disease: an identity crisis. J Hepatol 78:401\u2013414. https:\/\/doi.org\/10.1016\/j.jhep.2022.09.001","journal-title":"J Hepatol"},{"key":"3539_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/ueg2.12113","volume":"9","author":"ES Bj\u00f6rnsson","year":"2021","unstructured":"Bj\u00f6rnsson ES (2021) Clinical management of patients with drug-induced liver injury (DILI). United European Gastroenterol J 9:781\u2013786. https:\/\/doi.org\/10.1002\/ueg2.12113","journal-title":"United European Gastroenterol J"},{"key":"3539_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm.2016.94","volume":"17","author":"SJ Bray","year":"2016","unstructured":"Bray SJ (2016) Notch signalling in context. Nat Rev Mol Cell Biol 17:722\u2013735. https:\/\/doi.org\/10.1038\/nrm.2016.94","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"3539_CR13","doi-asserted-by":"publisher","first-page":"C817","DOI":"10.1152\/ajpcell.00139.2004","volume":"287","author":"PS Brookes","year":"2004","unstructured":"Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu S-S (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287(4):C817\u2013C833. https:\/\/doi.org\/10.1152\/ajpcell.00139.2004","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"3539_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40264-020-01026-y","volume":"44","author":"P Calverley","year":"2021","unstructured":"Calverley P, Rogliani P, Papi A (2021) Safety of N-Acetylcysteine at high doses in chronic respiratory diseases: a review. Drug Saf 44(3):273\u2013290. https:\/\/doi.org\/10.1007\/s40264-020-01026-y","journal-title":"Drug Saf"},{"key":"3539_CR15","doi-asserted-by":"publisher","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","volume":"20","author":"E Ceni","year":"2014","unstructured":"Ceni E, Mello T, Galli A (2014) Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol 20:17756\u201317772. https:\/\/doi.org\/10.3748\/wjg.v20.i47.17756","journal-title":"World J Gastroenterol"},{"key":"3539_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR (2023) Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr 32:197\u2013213. https:\/\/doi.org\/10.7570\/jomes23052","journal-title":"J Obes Metab Syndr"},{"key":"3539_CR17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/B978-0-12-804274-8.00052-7","volume-title":"Liver Pathophysiology","author":"E Ch\u00e1vez","year":"2017","unstructured":"Ch\u00e1vez E, Galicia-Moreno M, Muriel P (2017) Are N-acetylcysteine and resveratrol effective treatments for liver disease? In: Muriel P (ed) Liver Pathophysiology. Elsevier, pp 729\u2013744"},{"key":"3539_CR18","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.3390\/ijms21114084","volume":"21","author":"P Checconi","year":"2020","unstructured":"Checconi P, De Angelis M, Marcocci ME, Fraternale A, Magnani M, Palamara AT, Nencioni L (2020) Redox-modulating agents in the treatment of viral infections. Int J Mol Sci 21:4084\u20134105. https:\/\/doi.org\/10.3390\/ijms21114084","journal-title":"Int J Mol Sci"},{"key":"3539_CR19","first-page":"2627","volume":"12","author":"YY Choi","year":"2020","unstructured":"Choi YY, Seok JI, Hwang JI, Kim DS (2020) Co-administration of everolimus and N-acetylcysteine attenuates hepatic stellate cell activation and hepatic fibrosis. Am J Transl Res 12:2627\u20132639","journal-title":"Am J Transl Res"},{"key":"3539_CR20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/bcp.12880","volume":"81","author":"MF Chughlay","year":"2016","unstructured":"Chughlay MF, Kramer N, Spearman CW, Werfalli M, Cohen K (2016) N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review. Br J Clin Pharmacol 81:1021\u20131029. https:\/\/doi.org\/10.1111\/bcp.12880","journal-title":"Br J Clin Pharmacol"},{"key":"3539_CR21","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1074\/jbc.272.5.2700","volume":"272","author":"MR Ciriolo","year":"1997","unstructured":"Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Bu\u00e8 MC, De Vito P, Garaci E, Rotilioet G (1997) Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. J Biol Chem 272:2700\u20132708. https:\/\/doi.org\/10.1074\/jbc.272.5.2700","journal-title":"J Biol Chem"},{"key":"3539_CR22","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","volume":"20","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ (2014) Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol 20:2515\u20132532. https:\/\/doi.org\/10.3748\/wjg.v20.i10.2515","journal-title":"World J Gastroenterol"},{"key":"3539_CR23","doi-asserted-by":"publisher","first-page":"30269","DOI":"10.3390\/ijms161226225","volume":"16","author":"KQ De Andrade","year":"2015","unstructured":"De Andrade KQ, Moura FA, dos Santos JM, de Ara\u00fajo OR, de Farias Santos JC, Goulart MO (2015) Oxidative stress and inflammation in hepatic diseases: therapeutic possibilities of N-Acetylcysteine. Int J Mol Sci 16:30269\u201330308. https:\/\/doi.org\/10.3390\/ijms161226225","journal-title":"Int J Mol Sci"},{"key":"3539_CR24","doi-asserted-by":"publisher","first-page":"33881","DOI":"10.1074\/jbc.274.48.33881","volume":"274","author":"PJ De Bleser","year":"1999","unstructured":"De Bleser PJ, Xu G, Rombouts K, Rogiers V, Geerts A (1999) Glutathione levels discriminate between oxidative stress and transforming growth factor-\u03b2 signaling in activated rat hepatic stellate cells. J Biol Chem 274:33881\u201333887. https:\/\/doi.org\/10.1074\/jbc.274.48.33881","journal-title":"J Biol Chem"},{"key":"3539_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13046-018-1016-8","volume":"38","author":"J Deng","year":"2019","unstructured":"Deng J, Liu A-D, Hou G-Q, Zhang X, Ren K, Chen X-Z, Li SCS, Wu YS, Cao X (2019) N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling. J Exp Clin Cancer Res 38:2\u201317. https:\/\/doi.org\/10.1186\/s13046-018-1016-8","journal-title":"J Exp Clin Cancer Res"},{"key":"3539_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.lfs.2016.03.003","volume":"151","author":"IE Dhouib","year":"2016","unstructured":"Dhouib IE, Jallouli M, Annabi A, Gharbi N, Elfazaa S, Lasram MM (2016) A minireview on N -acetylcysteine: an old drug with new approaches. Life Sci 151:359\u2013363. https:\/\/doi.org\/10.1016\/j.lfs.2016.03.003","journal-title":"Life Sci"},{"key":"3539_CR27","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1039\/d1fo03952k","volume":"13","author":"Q Ding","year":"2022","unstructured":"Ding Q, Guo R, Pei L, Lai S, Li J, Yin Y, Xu T, Yang W, Song Q, Han Q, Dou X (2022) N-Acetylcysteine alleviates high fat diet-induced hepatic steatosis and liver injury via regulating the intestinal microecology in mice. Food Funct 13:3368\u20133380. https:\/\/doi.org\/10.1039\/d1fo03952k","journal-title":"Food Funct"},{"key":"3539_CR28","doi-asserted-by":"publisher","first-page":"104332","DOI":"10.1016\/j.phrs.2019.104332","volume":"146","author":"PV Dludla","year":"2019","unstructured":"Dludla PV, Mazibuko-Mbeje SE, Nyambuya TM, Mxinwa V, Tiano L, Marcheggiani F, Cirilli I, Louw J, Nkambule BB (2019) The beneficial effects of N-acetyl cysteine (NAC) against obesity associated complications: a systematic review of pre-clinical studies. Pharmacol Res 146:104332\u2013104346. https:\/\/doi.org\/10.1016\/j.phrs.2019.104332","journal-title":"Pharmacol Res"},{"key":"3539_CR29","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1517\/14728220802517901","volume":"8","author":"S Dodd","year":"2008","unstructured":"Dodd S, Dean O, Copolov DL, Malhi GS, Berk M (2008) N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther 8:1955\u20131962. https:\/\/doi.org\/10.1517\/14728220802517901","journal-title":"Expert Opin Biol Ther"},{"key":"3539_CR30","doi-asserted-by":"publisher","first-page":"e23560","DOI":"10.1002\/jbt.23560","volume":"38","author":"AC Dos Santos","year":"2024","unstructured":"Dos Santos AC, Fran\u00e7a TCS, Venzon L, Polli V, Polleti G, Trembulak E, Mendes-Pilati SF, Mota da Silva L (2024) Are silymarin and N-acetylcysteine able to prevent liver damage mediated by multiple factors? Findings against ethanol plus LPS-induced liver injury in mice. J Biochem Mol Toxicol 38:e23560. https:\/\/doi.org\/10.1002\/jbt.23560","journal-title":"J Biochem Mol Toxicol"},{"key":"3539_CR31","unstructured":"Ershad M, Naji A, Patel P, Vearrier D (2024) N-acetylcysteine. In: StatPearls. Treasure Island (FL): StatPearls Publishing"},{"key":"3539_CR32","doi-asserted-by":"publisher","first-page":"117832","DOI":"10.1016\/j.lfs.2020.117832","volume":"255","author":"F Firozian","year":"2020","unstructured":"Firozian F, Karami S, Ranjbar A, Azandaryani MT, Nili-Ahmadabadi A (2020) Improvement of therapeutic potential N-acetylcysteine in acetaminophen hepatotoxicity by encapsulation in PEGylated nano-niosomes. Life Sci 255:117832\u2013117840. https:\/\/doi.org\/10.1016\/j.lfs.2020.117832","journal-title":"Life Sci"},{"key":"3539_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman HJ, Zhang H (2021) Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov 20:689\u2013709. https:\/\/doi.org\/10.1038\/s41573-021-00233-1","journal-title":"Nat Rev Drug Discov"},{"key":"3539_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00003088-198207020-00001","volume":"7","author":"JA Forrest","year":"1982","unstructured":"Forrest JA, Clements JA, Prescott LF (1982) Clinical pharmacokinetics of paracetamol. Clin Pharmacokine 7:93\u2013107. https:\/\/doi.org\/10.2165\/00003088-198207020-00001","journal-title":"Clin Pharmacokine"},{"key":"3539_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.rgmx.2014.03.001","volume":"79","author":"M Galicia-Moreno","year":"2014","unstructured":"Galicia-Moreno M, Guti\u00e9rrez-Reyes G (2014) The role of oxidative stress in the development of alcoholic liver disease. Rev Gastroenterol Mex 79:135\u2013144. https:\/\/doi.org\/10.1016\/j.rgmx.2014.03.001","journal-title":"Rev Gastroenterol Mex"},{"key":"3539_CR36","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/MEG.0b013e32831f1f3a","volume":"21","author":"M Galicia-Moreno","year":"2009","unstructured":"Galicia-Moreno M, Rodr\u00edguez-Rivera A, Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P (2009) N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. Eur J Gastroenterol Hepatol 21:908\u2013914. https:\/\/doi.org\/10.1097\/MEG.0b013e32831f1f3a","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3539_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/MEG.0b013e32834f3123","volume":"24","author":"M Galicia-Moreno","year":"2012","unstructured":"Galicia-Moreno M, Favari L, Muriel P (2012) Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model. Eur J Gastroenterol Hepatol 24:179\u2013185. https:\/\/doi.org\/10.1097\/MEG.0b013e32834f3123","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3539_CR38","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/antiox9100980","volume":"9","author":"M Galicia-Moreno","year":"2020","unstructured":"Galicia-Moreno M, Lucano-Landeros S, Monroy-Ramirez HC, Silva-Gomez J, Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J (2020) Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects. Antioxidants (Basel) 9:980. https:\/\/doi.org\/10.3390\/antiox9100980","journal-title":"Antioxidants (Basel)"},{"key":"3539_CR39","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572\u20131585. https:\/\/doi.org\/10.1053\/j.gastro.2011.09.002","journal-title":"Gastroenterology"},{"key":"3539_CR40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/hep.510290346","volume":"29","author":"ER Garc\u00eda-Trevijano","year":"1999","unstructured":"Garc\u00eda-Trevijano ER, Iraburu MJ, Fontana L, Dom\u00ednguez-Rosales JA, Auster A, Covarrubias-Pinedo A, Rojkind M (1999) Transforming growth factor \u03b21induces the expression of \u03b11(i) procollagen mRNA by a hydrogen peroxide-C\/EBP\u03b2-dependent mechanism in rat hepatic stellate cells: transforming growth factor \u03b21 induces the expression of \u03b11(I) Procollagen mRNA by a hydrogen peroxide-C\/EBP\u03b2-dependent mechanism in rat hepatic stella. Hepatology 29:960\u2013970. https:\/\/doi.org\/10.1002\/hep.510290346","journal-title":"Hepatology"},{"key":"3539_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD (2020) Oxidative stress in cancer. Cancer Cell 38:167\u2013197. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.001","journal-title":"Cancer Cell"},{"key":"3539_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/15563650.2011.583664","volume":"49","author":"K Heard","year":"2011","unstructured":"Heard K, Schaeffer TH (2011) Massive acetylcysteine overdose associated with cerebral edema and seizures. Clin Toxicol (Phila) 49:423\u2013425. https:\/\/doi.org\/10.3109\/15563650.2011.583664","journal-title":"Clin Toxicol (Phila)"},{"key":"3539_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-4939-9420-5_8","volume":"1981","author":"R Heidari","year":"2019","unstructured":"Heidari R, Niknahad H (2019) The role and study of mitochondrial impairment and oxidative stress in cholestasis. Methods Mol Biol 1981:117\u2013132. https:\/\/doi.org\/10.1007\/978-1-4939-9420-5_8","journal-title":"Methods Mol Biol"},{"key":"3539_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.phanu.2018.09.001","volume":"6","author":"R Heidari","year":"2018","unstructured":"Heidari R, Ghanbarinejad V, Ommati MM, Jamshidzadeh A, Niknahad H (2018) Mitochondria protecting amino acids: application against a wide range of mitochondria-linked complications. PharmaNutrition 6:180\u2013190. https:\/\/doi.org\/10.1016\/j.phanu.2018.09.001","journal-title":"PharmaNutrition"},{"issue":"2","key":"3539_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5114\/ceh.2020.95814","volume":"6","author":"R Heidari","year":"2020","unstructured":"Heidari R, Ghanbarinejad V, Ommati MM, Jamshidzadeh A, Niknahad H, Mohammadi H, Sayad A, Mohammadi M, Niknahad H, Heidari R (2020) N-acetyl cysteine treatment preserves mitochondrial indices of functionality in the brain of hyperammonemic mice. Clinical and Experimental Hepatology 6(2):106\u2013115. https:\/\/doi.org\/10.5114\/ceh.2020.95814","journal-title":"Clinical and Experimental Hepatology"},{"key":"3539_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2011.200087","volume":"71","author":"B Hinz","year":"2012","unstructured":"Hinz B, Brune K (2012) Paracetamol and cyclooxygenase inhibition: is there a cause for concern? Ann Rheum Dis 71:20\u201325. https:\/\/doi.org\/10.1136\/ard.2011.200087","journal-title":"Ann Rheum Dis"},{"key":"3539_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","volume":"20","author":"MR Holdiness","year":"1991","unstructured":"Holdiness MR (1991) Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 20:123\u2013134. https:\/\/doi.org\/10.2165\/00003088-199120020-00004","journal-title":"Clin Pharmacokinet"},{"key":"3539_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00726-012-1295-x","volume":"45","author":"Y Hou","year":"2013","unstructured":"Hou Y, Wang L, Yi D, Ding B, Yang Z, Li J, Chen X, Qiu Y, Wu G (2013) N-acetylcysteine reduces inflammation in the small intestine by regulating redox, EGF and TLR4 signaling. Amino Acids 45:513\u2013522. https:\/\/doi.org\/10.1007\/s00726-012-1295-x","journal-title":"Amino Acids"},{"key":"3539_CR49","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.clinre.2015.01.003","volume":"39","author":"J Hu","year":"2015","unstructured":"Hu J, Zhang Q, Ren X, Sun Z, Quan Q (2015) Efficacy and safety of acetylcysteine in \u201cnon-acetaminophen\u201d acute liver failure: a meta-analysis of prospective clinical trials. Clin Res Hepatol Gastroenterol 39:594\u2013599. https:\/\/doi.org\/10.1016\/j.clinre.2015.01.003","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3539_CR50","doi-asserted-by":"publisher","first-page":"e24957","DOI":"10.1371\/journal.pone.0024957","volume":"6","author":"AV Ivanov","year":"2011","unstructured":"Ivanov AV, Smirnova OA, Ivanova ON, Masalova OV, Kochetkov SN, Isaguliants MG (2011) Hepatitis C virus proteins activate NRF2\/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. PLoS ONE 6:e24957\u2013e24968. https:\/\/doi.org\/10.1371\/journal.pone.0024957","journal-title":"PLoS ONE"},{"key":"3539_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1046\/j.1365-2036.1997.00209.x","volume":"11","author":"AL Jones","year":"1997","unstructured":"Jones AL, Jarvie DR, Simpson D, Hayes PC, Prescott LF (1997) Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease. Aliment Pharmacol Ther 11:787\u2013791. https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00209.x","journal-title":"Aliment Pharmacol Ther"},{"key":"3539_CR52","first-page":"12","volume":"10","author":"M Khoshbaten","year":"2010","unstructured":"Khoshbaten M, Aliasgarzadeh A, Masnadi K, Tarzamani MK, Farhang S, Babaei H, Kiani J, Zaare M, Najafipoor F (2010) N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease. Hepat Mon 10:12\u201316","journal-title":"Hepat Mon"},{"key":"3539_CR53","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s12276-020-00527-1","volume":"52","author":"E Kim","year":"2020","unstructured":"Kim E, Viatour P (2020) Hepatocellular carcinoma: old friends and new tricks. Exp Mol Med 52:1898\u20131907. https:\/\/doi.org\/10.1038\/s12276-020-00527-1","journal-title":"Exp Mol Med"},{"key":"3539_CR54","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/ijms20112712","volume":"20","author":"LZ Kong","year":"2019","unstructured":"Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T (2019) Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease. Int J Mol Sci 20:2712\u20132739. https:\/\/doi.org\/10.3390\/ijms20112712","journal-title":"Int J Mol Sci"},{"key":"3539_CR55","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jhep.2017.07.005","volume":"67","author":"WM Lee","year":"2017","unstructured":"Lee WM (2017) Acetaminophen (APAP) hepatotoxicity\u2014isn\u2019t it time for APAP to go away? J Hepatol 67:1324\u20131331. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.005","journal-title":"J Hepatol"},{"key":"3539_CR56","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","volume":"137","author":"WM Lee","year":"2009","unstructured":"Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern TJ, Murray NG, McCashland T, Reisch JS, Robuck PR, Acute Liver Failure Study Group (2009) Intravenous N-acetylcysteine improves transplant-free survival in early-stage non-acetaminophen acute liver failure. Gastroenterology 137:856\u2013864. https:\/\/doi.org\/10.1053\/j.gastro.2009.06.006","journal-title":"Gastroenterology"},{"key":"3539_CR57","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1099\/vir.0.000134","volume":"96","author":"H Lee","year":"2015","unstructured":"Lee H, Kim H, Lee S-A, Won Y-S, Kim H-I, Inn KS, Kim B-J (2015) Upregulation of endoplasmic reticulum stress and reactive oxygen species by naturally occurring mutations in hepatitis B virus core antigen. J Gen Virol 96:1850\u20131854. https:\/\/doi.org\/10.1099\/vir.0.000134","journal-title":"J Gen Virol"},{"key":"3539_CR58","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/hep.30467","volume":"69","author":"D Lee","year":"2019","unstructured":"Lee D, Xu IM-J, Chiu DK-C, Leibold J, Tse AP-W, Bao MH-R, Yuen VW-H, Chan CY-K, Lai RK-H, Chin DW-C, Chan DF-F, Cheung T-T, Chok S-H, Wong C-M, Lowe S-W, Ng IO-L, Wong CC-L (2019) Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma. Hepatology 69:1768\u20131786. https:\/\/doi.org\/10.1002\/hep.30467","journal-title":"Hepatology"},{"key":"3539_CR59","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s13046-019-1459-6","volume":"38","author":"J Li","year":"2019","unstructured":"Li J, Wang Q, Yang Y, Lei C, Yang F, Liang L, Chen C, Xia J, Wang K, Tang N (2019) GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1\/NRF2 pathway. J Exp Clin Cancer Res 38:438\u2013455. https:\/\/doi.org\/10.1186\/s13046-019-1459-6","journal-title":"J Exp Clin Cancer Res"},{"key":"3539_CR60","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1053\/j.gastro.2008.07.027","volume":"135","author":"SO Lim","year":"2008","unstructured":"Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135:2128\u20132140. https:\/\/doi.org\/10.1053\/j.gastro.2008.07.027","journal-title":"Gastroenterology"},{"key":"3539_CR61","doi-asserted-by":"publisher","first-page":"e74130","DOI":"10.1371\/journal.pone.0074130","volume":"8","author":"H Lin","year":"2013","unstructured":"Lin H, Liu XB, Yu JJ, Hua F, Hu ZW (2013) Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS\/ER stress in TLR2 deficient mouse. PLoS ONE 8:e74130\u2013e74138. https:\/\/doi.org\/10.1371\/journal.pone.0074130","journal-title":"PLoS ONE"},{"key":"3539_CR62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13046-021-01829-6","volume":"40","author":"Z Lin","year":"2021","unstructured":"Lin Z, Huang W, He Q, Li D, Wang Z, Feng Y, Liu D, Zhang T, Wang Y, Xie M, Ji X, Sun M, Tian D, Xia L (2021) FOXC1 promotes HCC proliferation and metastasis by upregulating DNMT3B to induce DNA hypermethylation of CTH promoter. J Exp Clin Cancer Res 40:50\u201370. https:\/\/doi.org\/10.1186\/s13046-021-01829-6","journal-title":"J Exp Clin Cancer Res"},{"key":"3539_CR63","doi-asserted-by":"publisher","first-page":"e29052","DOI":"10.5812\/hepatmon.29052v2","volume":"15","author":"LH Long","year":"2015","unstructured":"Long LH, Xue CQ, Shi JF, Dong JN, Wang L (2015) Efficacy of hepatoprotective agents with or without antiviral drugs on liver function and fibrosis in patients with hepatitis B: a meta-analysis. Hepat Mon 15:e29052\u2013e29064. https:\/\/doi.org\/10.5812\/hepatmon.29052v2","journal-title":"Hepat Mon"},{"key":"3539_CR64","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","volume":"8","author":"T Luedde","year":"2011","unstructured":"Luedde T, Schwabe RF (2011) NF-\u03baB in the liver\u2014linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 8:108\u2013118. https:\/\/doi.org\/10.1038\/nrgastro.2010.213","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3539_CR65","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/hep.27131","volume":"60","author":"DA Mann","year":"2014","unstructured":"Mann DA (2014) Epigenetics in liver disease. Hepatology 60:1418\u20131425. https:\/\/doi.org\/10.1002\/hep.27131","journal-title":"Hepatology"},{"key":"3539_CR66","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/bmj.289.6439.217","volume":"289","author":"TG Mant","year":"1984","unstructured":"Mant TG, Tempowski JH, Volans GN, Talbot JC (1984) Adverse reactions to acetylcysteine and effects of overdose. Br Med J (Clin Res Ed) 289:217\u2013219. https:\/\/doi.org\/10.1136\/bmj.289.6439.217","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3539_CR67","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4149\/BLL_2017_106","volume":"118","author":"LQ Mao","year":"2017","unstructured":"Mao LQ, Li XB (2017) Effects of N-acetyl cysteine to improve acute lung injury in rats. Bratisl Lek Listy 118:552\u2013556. https:\/\/doi.org\/10.4149\/BLL_2017_106","journal-title":"Bratisl Lek Listy"},{"key":"3539_CR68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73:4\u201313. https:\/\/doi.org\/10.1002\/hep.31288","journal-title":"Hepatology"},{"key":"3539_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9012580","volume":"2016","author":"R Medvedev","year":"2016","unstructured":"Medvedev R, Ploen D, Hildt E (2016) HCV and oxidative stress: implications for HCV life cycle and HCV-associated pathogenesis. Oxid Med Cell Longev 2016:1\u201313. https:\/\/doi.org\/10.1155\/2016\/9012580","journal-title":"Oxid Med Cell Longev"},{"key":"3539_CR70","doi-asserted-by":"publisher","first-page":"596","DOI":"10.4254\/wjh.v12.i9.596","volume":"12","author":"C Minsart","year":"2020","unstructured":"Minsart C, Rorive S, Lemmers A, Quertinmont E, Gustot T (2020) N-acetylcysteine and glycyrrhizin combination: benefit outcome in a murine model of acetaminophen-induced liver failure. World J Hepatol 12:596\u2013618. https:\/\/doi.org\/10.4254\/wjh.v12.i9.596","journal-title":"World J Hepatol"},{"key":"3539_CR71","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/cbin.11670","volume":"45","author":"IH Mir","year":"2021","unstructured":"Mir IH, Guha S, Behera J, Thirunavukkarasu C (2021) Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy. Cell Biol Int 45:2161\u20132177. https:\/\/doi.org\/10.1002\/cbin.11670","journal-title":"Cell Biol Int"},{"key":"3539_CR72","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fphar.2018.00453","volume":"9","author":"A Moles","year":"2018","unstructured":"Moles A, Torres S, Baulies A, Garcia-Ruiz C, Fernandez-Checa JC (2018) Mitochondrial\u2013lysosomal axis in acetaminophen hepatotoxicity. Front Pharmacol 9:453. https:\/\/doi.org\/10.3389\/fphar.2018.00453","journal-title":"Front Pharmacol"},{"key":"3539_CR73","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/j.seminoncol.2017.10.001","volume":"44","author":"D Monti","year":"2017","unstructured":"Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, Lazar M, Cotzia P, Draganova-Tacheva R, Lin Z, Domingo-Vidal M, Newberg A, Lisanti MP, Martinez-Outschoorn, (2017) Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in breast cancer. Semin Oncol 44:226\u2013232. https:\/\/doi.org\/10.1053\/j.seminoncol.2017.10.001","journal-title":"Semin Oncol"},{"key":"3539_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/fsn3.3","volume":"1","author":"SM Moore","year":"2013","unstructured":"Moore SM, Kremer M, Sanderlin EJ, Wheeler MD, Hines IN (2013) Emerging roles for lipids in the hepatic innate immune response. Hum Nutr Food Sci 1:1\u20139","journal-title":"Hum Nutr Food Sci"},{"key":"3539_CR75","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jat.1393","volume":"29","author":"P Muriel","year":"2009","unstructured":"Muriel P (2009) NF-\u03baB in liver diseases: a target for drug therapy. J Appl Toxicol 29:91\u2013100. https:\/\/doi.org\/10.1002\/jat.1393","journal-title":"J Appl Toxicol"},{"key":"3539_CR76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fimmu.2014.00221","volume":"5","author":"N Nakamoto","year":"2014","unstructured":"Nakamoto N, Kanai T (2014) Role of toll-like receptors in immune activation and tolerance in the liver. Front Immunol 5:221\u2013228. https:\/\/doi.org\/10.3389\/fimmu.2014.00221","journal-title":"Front Immunol"},{"key":"3539_CR77","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1349-7006.2001.tb01089.x","volume":"92","author":"T Nakatani","year":"2001","unstructured":"Nakatani T, Roy G, Fujimoto N, Asahara T, Ito A (2001) Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin. Jpn J Cancer Res 92:249\u2013256. https:\/\/doi.org\/10.1111\/j.1349-7006.2001.tb01089.x","journal-title":"Jpn J Cancer Res"},{"key":"3539_CR78","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","volume":"365","author":"E Nguyen-Khac","year":"2011","unstructured":"Nguyen-Khac E, Thevenot T, Piquet M-A, Benferhat S, Goria O, Chatelain D, Tramier B, Dewaele F, Ghrib S, Rudler M, Carbonell N, Tossou H, Bental A, Bernard-Chabert B, Dupas J-L (2011) AAH-NAC Study Group (2011) Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med 365:1781\u20131789. https:\/\/doi.org\/10.1056\/NEJMoa1101214","journal-title":"N Engl J Med"},{"key":"3539_CR79","doi-asserted-by":"publisher","first-page":"100343","DOI":"10.1016\/j.phanu.2023.100343","volume":"24","author":"M Nikbaf-Shandiz","year":"2023","unstructured":"Nikbaf-Shandiz M, Adeli S, Hossein Faghfouri A, Khademi F, Jamilian P, Zarezadeh M, Ebrahimi-Mamaghani M (2023) The efficacy of N-acetylcysteine in improving liver function: a systematic review and meta-analysis of controlled clinical trials. Pharma Nutrition 24:100343\u2013100352. https:\/\/doi.org\/10.1016\/j.phanu.2023.100343","journal-title":"Pharma Nutrition"},{"key":"3539_CR80","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000355243","volume":"31","author":"N Nishida","year":"2013","unstructured":"Nishida N, Kudo M (2013) Oxidative stress and epigenetic instability in human hepatocarcinogenesis. Dig Dis 31:447\u2013453. https:\/\/doi.org\/10.1159\/000355243","journal-title":"Dig Dis"},{"key":"3539_CR81","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.3390\/ijms19103103","volume":"19","author":"K Nishikawa","year":"2018","unstructured":"Nishikawa K, Osawa Y, Kimura K (2018) patientsWnt\/\u03b2-catenin signaling as a potential target for the treatment of liver cirrhosis using antifibrotic drugs. Int J Mol Sci 19:3103\u20133115. https:\/\/doi.org\/10.3390\/ijms19103103","journal-title":"Int J Mol Sci"},{"key":"3539_CR82","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.2215\/CJN.00210110","volume":"5","author":"TD Nolin","year":"2010","unstructured":"Nolin TD, Ouseph R, Himmelfarb J, McMenamin ME, Ward RA (2010) Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease. Clin J Am Soc Nephrol 5:1588\u20131594. https:\/\/doi.org\/10.2215\/CJN.00210110","journal-title":"Clin J Am Soc Nephrol"},{"key":"3539_CR83","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/s0014-5793(00)01464-2","volume":"472","author":"S-I Oka","year":"2000","unstructured":"Oka S-I, Kamata H, Kamata K, Yagisawa H, Hirata H (2000) N-Acetylcysteine suppresses TNF-induced NF-\u03baB activation through inhibition of I\u03baB kinases. FEBS Lett 472:196\u2013202. https:\/\/doi.org\/10.1016\/s0014-5793(00)01464-2","journal-title":"FEBS Lett"},{"key":"3539_CR84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1590\/S0004-2803.201900000-36","volume":"56","author":"CP Oliveira","year":"2019","unstructured":"Oliveira CP, Cotrim HP, Stefano JT, Siqueira ACG, Salgado ALA, Parise ER (2019) N-acetylcysteine and\/or ursodeoxycholic acid associated with metformin in non-alcoholic steatohepatitis: an open-label multicenter randomized controlled trial. Arq Gastroenterol 56:184\u2013190. https:\/\/doi.org\/10.1590\/S0004-2803.201900000-36","journal-title":"Arq Gastroenterol"},{"key":"3539_CR85","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/10253890.2020.1777970","volume":"24","author":"MM Ommati","year":"2021","unstructured":"Ommati MM, Amjadinia A, Mousavi K, Azarpira N, Jamshidzadeh A, Heidari R (2021) N-acetyl cysteine treatment mitigates biomarkers of oxidative stress in different tissues of bile duct ligated rats. Stress 24:213\u2013228. https:\/\/doi.org\/10.1080\/10253890.2020.1777970","journal-title":"Stress"},{"key":"3539_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4149\/gpb_2017016","volume":"37","author":"O Otrubov\u00e1","year":"2018","unstructured":"Otrubov\u00e1 O, Tureck\u00fd L, Uli\u010dn\u00e1 O, Janega P, Luha J, Muchov\u00e1 J (2018) Therapeutic effects of N-acetyl-L-cysteine on liver damage induced by long-term CCl4 administration. Gen Physiol Biophys 37:23\u201331. https:\/\/doi.org\/10.4149\/gpb_2017016","journal-title":"Gen Physiol Biophys"},{"key":"3539_CR87","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1046\/j.1440-1746.2003.03156.x","volume":"18","author":"GE Pamuk","year":"2003","unstructured":"Pamuk GE, Sonsuz A (2003) N-acetylcysteine in the treatment of non-alcoholic steatohepatitis. J Gastroenterol Hepatol 18:1214\u20131224. https:\/\/doi.org\/10.1046\/j.1440-1746.2003.03156.x","journal-title":"J Gastroenterol Hepatol"},{"key":"3539_CR88","doi-asserted-by":"publisher","first-page":"14784","DOI":"10.1038\/s41598-019-51377-5","volume":"9","author":"R Parsanathan","year":"2019","unstructured":"Parsanathan R, Jain SK (2019) Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice. Sci Rep 9:14784\u201314795. https:\/\/doi.org\/10.1038\/s41598-019-51377-5","journal-title":"Sci Rep"},{"key":"3539_CR89","doi-asserted-by":"publisher","first-page":"2835787","DOI":"10.1155\/2018\/2835787","volume":"2018","author":"Y Pei","year":"2018","unstructured":"Pei Y, Liu H, Yang Y, Yang Y, Jiao Y, Tay FR, Chen J (2018) Biological activities and potential oral applications of N-acetylcysteine: progress and prospects. Oxid Med Cell Longev 2018:2835787\u20132835801. https:\/\/doi.org\/10.1155\/2018\/2835787","journal-title":"Oxid Med Cell Longev"},{"key":"3539_CR90","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ijc.32723","volume":"147","author":"JL Petrick","year":"2020","unstructured":"Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, Ferlay J, Valery PC, Bray F, McGlynn KA (2020) International trends in hepatocellular carcinoma incidence, 1978\u20132012. Int J Cancer 147:317\u2013330. https:\/\/doi.org\/10.1002\/ijc.32723","journal-title":"Int J Cancer"},{"key":"3539_CR91","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.3390\/ijms15058591","volume":"15","author":"W Peverill","year":"2014","unstructured":"Peverill W, Powell L, Skoien R (2014) Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci 15:8591\u20135638. https:\/\/doi.org\/10.3390\/ijms15058591","journal-title":"Int J Mol Sci"},{"key":"3539_CR92","unstructured":"Poznyak V, Rekve V (2018) Global status report on alcohol and health 2018. World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/9789241565639. Accessed Oct 2024"},{"key":"3539_CR93","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.crphar.2022.100084","volume":"3","author":"V Puri","year":"2022","unstructured":"Puri V, Chaudhary KR, Singh A, Singh C (2022) Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: In vitro lung deposition and efficacy studies. Curr Res Pharmacol Drug Discov 3:100084\u2013100095. https:\/\/doi.org\/10.1016\/j.crphar.2022.100084","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"3539_CR94","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.vetimm.2013.01.013","volume":"152","author":"Y Qiu","year":"2013","unstructured":"Qiu Y, Zhang J, Liu Y, Ma H, Cao F, Xu J, Hou Y, Xu L (2013) The combination effects of acetaminophen and N-acetylcysteine on cytokines production and NF-\u03baB activation of lipopolysaccharide-challenged piglet mononuclear phagocytes in vitro and in vivo. Vet Immunol Immunopathol 152:381\u2013388. https:\/\/doi.org\/10.1016\/j.vetimm.2013.01.013","journal-title":"Vet Immunol Immunopathol"},{"key":"3539_CR95","doi-asserted-by":"publisher","first-page":"e643","DOI":"10.1097\/md.0000000000000643","volume":"94","author":"BG Qu","year":"2015","unstructured":"Qu BG, Wang H, Jia YG, Su JL, Wang ZD, Wang YF, Han XH, Liu YX, Pan JD, Ren GY (2015) Changes in tumor necrosis factor-\u03b1, heat shock protein 70, malondialdehyde, and superoxide dismutase in patients with different severities of alcoholic fatty liver disease: a prospective observational study. Medicine (Baltimore) 94:e643\u2013e647. https:\/\/doi.org\/10.1097\/md.0000000000000643","journal-title":"Medicine (Baltimore)"},{"key":"3539_CR96","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jat.3880","volume":"40","author":"E Ramos-Tovar","year":"2020","unstructured":"Ramos-Tovar E, Muriel P (2020) Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage. J Appl Toxicol 40:151\u2013168. https:\/\/doi.org\/10.1002\/jat.3880","journal-title":"J Appl Toxicol"},{"key":"3539_CR97","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","volume":"72","author":"S Rebouissou","year":"2020","unstructured":"Rebouissou S, Nault JC (2020) Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol 72:215\u2013229. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.017","journal-title":"J Hepatol"},{"key":"3539_CR98","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TM, Powell EE, Roden M, Romero-G\u00f3mez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW-S, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78:1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"3539_CR99","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF (2020) Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells 9:875\u2013918. https:\/\/doi.org\/10.3390\/cells9040875","journal-title":"Cells"},{"key":"3539_CR100","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/cells9040875","volume":"11","author":"AA Sablina","year":"2005","unstructured":"Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM (2005) The antioxidant function of the p53 tumor suppressor. Nat Med 11:1306\u20131313. https:\/\/doi.org\/10.3390\/cells9040875","journal-title":"Nat Med"},{"key":"3539_CR101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pupt.2005.12.007","volume":"20","author":"AM Sadowska","year":"2007","unstructured":"Sadowska AM, Manuel-Y-Keenoy B, De Backer WA (2007) Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 20:9\u201322. https:\/\/doi.org\/10.1016\/j.pupt.2005.12.007","journal-title":"Pulm Pharmacol Ther"},{"key":"3539_CR102","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","volume":"1830","author":"Y Samuni","year":"2013","unstructured":"Samuni Y, Goldstein S, Dean OM, Berk M (2013) The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 1830:4117\u20134129. https:\/\/doi.org\/10.1016\/j.bbagen.2013.04.016","journal-title":"Biochim Biophys Acta"},{"key":"3539_CR103","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/alcalc\/agl077","volume":"41","author":"MJ S\u00e1nchez P\u00e9rez","year":"2006","unstructured":"S\u00e1nchez P\u00e9rez MJ, Gonz\u00e1lez-Reimers E, Santolaria-Fern\u00e1ndez F, de la Vega-Prieto MJ, Mart\u00ednez-Riera A, Gonz\u00e1lez PA, Rodr\u00edguez Rodr\u00edguez E, Dur\u00e1n-Castell\u00f3n MC (2006) Lipid peroxidation and serum cytokines in acute alcoholic hepatitis. Alcohol Alcohol 41:593\u2013597. https:\/\/doi.org\/10.1093\/alcalc\/agl077","journal-title":"Alcohol Alcohol"},{"key":"3539_CR104","doi-asserted-by":"publisher","first-page":"e45285","DOI":"10.1371\/journal.pone.0045285","volume":"7","author":"P Sancho","year":"2012","unstructured":"Sancho P, Mainez J, Crosas-Molist E, Roncero C, Fern\u00e1ndez-Rodriguez CM, Pinedo F, Huber H, Eferl R, Mikulits W, Fabregat I (2012) NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS ONE 7:e45285\u2013e45299. https:\/\/doi.org\/10.1371\/journal.pone.0045285","journal-title":"PLoS ONE"},{"key":"3539_CR105","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15563650802665587","volume":"47","author":"EA Sandilands","year":"2009","unstructured":"Sandilands EA, Bateman DN (2009) Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 47:81\u201388. https:\/\/doi.org\/10.1080\/15563650802665587","journal-title":"Clin Toxicol (Phila)"},{"key":"3539_CR106","doi-asserted-by":"publisher","first-page":"e35852","DOI":"10.7759\/cureus.35852","volume":"15","author":"S Sharieff","year":"2023","unstructured":"Sharieff S, Idrees A, Rafai W, Bukhari SUS (2023) Use of oral N-Acetylcysteine (NAC) in non-acetaminophen-induced acute hepatic failure. Cureus 15:e35852\u2013e35857. https:\/\/doi.org\/10.7759\/cureus.35852","journal-title":"Cureus"},{"key":"3539_CR107","doi-asserted-by":"publisher","first-page":"G705","DOI":"10.1152\/ajpgi.00314.2015","volume":"310","author":"PK Shukla","year":"2016","unstructured":"Shukla PK, Gangwar R, Manda B, Meena AS, Yadav N, Szabo E, Balogh A, Lee SC, Tigyi G, Rao R (2016) Rapid disruption of intestinal epithelial tight junction and barrier dysfunction by ionizing radiation in mouse colon in vivo: protection by N-acetyl-l-cysteine. Am J Physiol Gastrointest Liver Physiol 310:G705\u2013G715. https:\/\/doi.org\/10.1152\/ajpgi.00314.2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3539_CR108","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1007\/s10620-019-05652-0","volume":"64","author":"S Siramolpiwat","year":"2019","unstructured":"Siramolpiwat S, Punjachaipornpon T, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Tangaroonsanti A, Bhanthumkomol P, Phumyen A, Yasiri A, Kaewmanee M (2019) N-acetylcysteine prevents post-embolization syndrome in patients with hepatocellular carcinoma following transarterial chemoembolization. Dig Dis Sci 64:3337\u20133345. https:\/\/doi.org\/10.1007\/s10620-019-05652-0","journal-title":"Dig Dis Sci"},{"key":"3539_CR109","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.2147\/IJN.S204372","volume":"14","author":"K Sooklert","year":"2019","unstructured":"Sooklert K, Nilyai S, Rojanathanes R, Jindatip D, Sae-Liang N, Kitkumthorn N, Mutirangura A, Sereemaspun A (2019) N-acetylcysteine reverses the decrease of DNA methylation status caused by engineered gold, silicon, and chitosan nanoparticles. Int J Nanomedicine 14:4573\u20134587. https:\/\/doi.org\/10.2147\/IJN.S204372","journal-title":"Int J Nanomedicine"},{"key":"3539_CR110","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000444557","volume":"34","author":"JP Sowa","year":"2016","unstructured":"Sowa JP, Gerken G, Canbay A (2016) Acute liver failure - it\u2019s just a matter of cell death. Dig Dis 34:423\u2013428. https:\/\/doi.org\/10.1159\/000444557","journal-title":"Dig Dis"},{"key":"3539_CR111","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/hep.26001","volume":"57","author":"RH Squires","year":"2013","unstructured":"Squires RH, Dhawan A, Alonso E, Narkewicz MR, Shneider BL, Rodriguez-Baez N, Olio DD, Karpen S, Bucuvalas J, Lobritto S, Rand E, Rosenthal P, Horslen S, Ng V, Subbarao G, Kerkar N, Rudnick D, Lopez MJ, Schwarz K, Romero R, Elisofon S, Doo E, Robuck PR, Lawlor S, Belle SH, Pediatric Acute Liver Failure Study Group (2013) Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology 57:1542\u20131549. https:\/\/doi.org\/10.1002\/hep.26001","journal-title":"Hepatology"},{"key":"3539_CR112","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M (2018) Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol 53:362\u2013376. https:\/\/doi.org\/10.1007\/s00535-017-1415-1","journal-title":"J Gastroenterol"},{"key":"3539_CR113","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.3390\/molecules23123305","volume":"23","author":"G Tardiolo","year":"2018","unstructured":"Tardiolo G, Bramanti P, Mazzon E (2018) Overview on the effects of N-acetylcysteine in neurodegenerative diseases. Molecules 23:3305\u20133325. https:\/\/doi.org\/10.3390\/molecules23123305","journal-title":"Molecules"},{"key":"3539_CR114","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/antiox10060967","volume":"10","author":"MCDS Ten\u00f3rio","year":"2021","unstructured":"Ten\u00f3rio MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF (2021) N-Acetylcysteine (NAC): impacts on human health. Antioxidants (Basel) 10:967\u20131001. https:\/\/doi.org\/10.3390\/antiox10060967","journal-title":"Antioxidants (Basel)"},{"key":"3539_CR115","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/B978-0-12-804274-8.00002-3","volume-title":"Liver Pathophysiology","author":"V Tsutsumi","year":"2017","unstructured":"Tsutsumi V, Nakamura T, Ueno T, Torimura T, Aguirre-Garc\u00eda J (2017) Structure and ultrastructure of the normal and diseased liver. In: Muriel P (ed) Liver Pathophysiology. Elsevier, pp 23\u201344"},{"key":"3539_CR116","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jcb.240590805","volume":"59","author":"N van Zandwijk","year":"1995","unstructured":"van Zandwijk N (1995) N-Acetylcysteine (NAC) and glutathione (GSH): antioxidant and chemopreventive properties, with special reference to lung cancer. J Cell Biochem 59:24\u201332. https:\/\/doi.org\/10.1002\/jcb.240590805","journal-title":"J Cell Biochem"},{"key":"3539_CR117","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40139-013-0024-9","volume":"1","author":"T Wang","year":"2013","unstructured":"Wang T, Weinman SA (2013) Interactions between hepatitis C virus and mitochondria: impact on pathogenesis and innate immunity. Curr Pathobiol Rep 1:179\u2013187. https:\/\/doi.org\/10.1007\/s40139-013-0024-9","journal-title":"Curr Pathobiol Rep"},{"key":"3539_CR118","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.hepres.2005.12.005","volume":"34","author":"AL Wang","year":"2006","unstructured":"Wang AL, Wang JP, Wang H, Chen YH, Zhao L, Wang LS, Wei W, Xu D-X (2006) A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice. Hepatol Res 34:199\u2013206. https:\/\/doi.org\/10.1016\/j.hepres.2005.12.005","journal-title":"Hepatol Res"},{"key":"3539_CR119","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/alcalc\/agt167","volume":"49","author":"C Wang","year":"2014","unstructured":"Wang C, Li X, Wang H, Xie Q, Xu Y (2014) Notch1-nuclear factor \u03baB involves in oxidative stress-induced alcoholic steatohepatitis. Alcohol Alcohol 49:10\u201316. https:\/\/doi.org\/10.1093\/alcalc\/agt167","journal-title":"Alcohol Alcohol"},{"key":"3539_CR120","doi-asserted-by":"publisher","first-page":"189785","DOI":"10.1155\/2015\/189785","volume":"2015","author":"C Wang","year":"2015","unstructured":"Wang C, Xia Y, Zheng Y, Dai W, Wang F, Chen K, Li J, Li S, Zhu R, Yang J, Yin Q, Zhang H, Wang J, Lu J, Zhou Y, Guo C (2015) Protective effects of N-acetylcysteine in concanavalin A-induced hepatitis in mice. Mediators Inflamm 2015:189785\u2013189802. https:\/\/doi.org\/10.1155\/2015\/189785","journal-title":"Mediators Inflamm"},{"key":"3539_CR121","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s10753-016-0327-1","volume":"39","author":"LL Wang","year":"2016","unstructured":"Wang LL, Huang YH, Yan CY, Wei XD, Hou JQ, Pu JX, Lv JX (2016) N-acetylcysteine ameliorates prostatitis via miR-141 regulating Keap1\/Nrf2 signaling. Inflammation 39:938\u2013947. https:\/\/doi.org\/10.1007\/s10753-016-0327-1","journal-title":"Inflammation"},{"key":"3539_CR122","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.62347\/mtlw1449","volume":"14","author":"G Wong","year":"2024","unstructured":"Wong G, Wu SY, Chen WM, Hsu PJ, Chou TC, Chiang MF, Wu MS, Lee MC, Soong RS (2024) Effects of N-acetylcysteine on hepatocellular carcinoma in chronic hepatitis C. Am J Cancer Res 14:3533\u20133544. https:\/\/doi.org\/10.62347\/mtlw1449","journal-title":"Am J Cancer Res"},{"key":"3539_CR123","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.62347\/qlhg1014","volume":"14","author":"SY Wu","year":"2024","unstructured":"Wu SY, Chen WM, Hsu PJ, Chou TC, Chiang MF, Wu MS, Lee MC, Soong RS (2024) Protective effect of N-acetylcysteine against hepatocellular carcinoma in hepatitis B virus carriers. Am J Cancer Res 14:3639\u20133651. https:\/\/doi.org\/10.62347\/qlhg1014","journal-title":"Am J Cancer Res"},{"key":"3539_CR124","doi-asserted-by":"publisher","first-page":"109699","DOI":"10.1016\/j.abb.2023.109699","volume":"744","author":"L Xing","year":"2023","unstructured":"Xing L, Tang Y, Li L, Tao X (2023) ROS in hepatocellular carcinoma: What we know. Arch Biochem Biophys 744:109699\u2013109711. https:\/\/doi.org\/10.1016\/j.abb.2023.109699","journal-title":"Arch Biochem Biophys"},{"key":"3539_CR125","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.3390\/ijms19092563","volume":"19","author":"JP Yang","year":"2018","unstructured":"Yang JP, Shin JH, Seo SH, Kim SG, Lee S, Shin EH (2018) Effects of antioxidants in reducing accumulation of fat in hepatocyte. Int J Mol Sci 19:2563\u20132580. https:\/\/doi.org\/10.3390\/ijms19092563","journal-title":"Int J Mol Sci"},{"key":"3539_CR126","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/nu11040872","volume":"11","author":"J Yang","year":"2019","unstructured":"Yang J, Fern\u00e1ndez-Galilea M, Mart\u00ednez-Fern\u00e1ndez L, Gonz\u00e1lez-Muniesa P, P\u00e9rez-Ch\u00e1vez A, Mart\u00ednez JA, Moreno-Aliaga MJ (2019) Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation. Nutrients 11:872\u2013909. https:\/\/doi.org\/10.3390\/nu11040872","journal-title":"Nutrients"},{"key":"3539_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0007114522001829","volume":"17","author":"W Yang","year":"2022","unstructured":"Yang W, Guo R, Pi A, Ding Q, Hao L, Song Q, Chen L, Dou X, Na L, Li S (2022) Long non-coding RNA-EN_181 potentially contributes to the protective effects of N-acetylcysteine against non-alcoholic fatty liver disease in mice. Br J Nutr 17:1\u201315. https:\/\/doi.org\/10.1017\/S0007114522001829","journal-title":"Br J Nutr"},{"key":"3539_CR128","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s13181-018-0653-9","volume":"14","author":"M Yarema","year":"2018","unstructured":"Yarema M, Chopra P, Sivilotti MLA, Johnson D, Nettel-Aguirre A, Bailey B, Victorino C, Gosselin S, Purssell R, Thompson M, Spyker D, Rumack B (2018) Anaphylactoid reactions to intravenous N-acetylcysteine during treatment for acetaminophen poisoning. J Med Toxicol 14:120\u2013127. https:\/\/doi.org\/10.1007\/s13181-018-0653-9","journal-title":"J Med Toxicol"},{"key":"3539_CR129","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2012.06.008","volume":"22","author":"JS You","year":"2012","unstructured":"You JS, Jones PA (2012) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22:9\u201320. https:\/\/doi.org\/10.1016\/j.ccr.2012.06.008","journal-title":"Cancer Cell"},{"key":"3539_CR130","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/hep.29724","volume":"68","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Loomba R, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Lavine JE, Mathurin P, Charlton MR, Chalasani NP, Anstee QM, Kowdley KV, George J, Goodman ZD, Lindor K (2018) Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 68:361\u2013371. https:\/\/doi.org\/10.1002\/hep.29724","journal-title":"Hepatology"},{"key":"3539_CR131","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2015.07.048","volume":"369","author":"X Yuan","year":"2015","unstructured":"Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S, Wu GS, Wu K (2015) Notch signaling: an emerging therapeutic target for cancer treatment. Cancer Lett 369:20\u201327. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.048","journal-title":"Cancer Lett"},{"key":"3539_CR132","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ecoenv.2019.02.035","volume":"173","author":"C Yuan","year":"2019","unstructured":"Yuan C, Wang L, Zhu L, Ran B, Xue X, Wang Z (2019) N-acetylcysteine alleviated bisphenol A-induced testicular DNA hypermethylation of rare minnow (Gobiocypris rarus) by increasing cysteine contents. Ecotoxicol Environ Saf 173:243\u2013250. https:\/\/doi.org\/10.1016\/j.ecoenv.2019.02.035","journal-title":"Ecotoxicol Environ Saf"},{"key":"3539_CR133","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s000180300001","volume":"60","author":"M Zafarullah","year":"2003","unstructured":"Zafarullah M, Li WQ, Sylvester J, Ahmad M (2003) Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60:6\u201320. https:\/\/doi.org\/10.1007\/s000180300001","journal-title":"Cell Mol Life Sci"},{"key":"3539_CR134","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/fcp.12926","volume":"37","author":"MY Zamanian","year":"2023","unstructured":"Zamanian MY, Soltani A, Khodarahmi Z, Alameri AA, Alwan AMR, Ram\u00edrez-Coronel AA, Obaid RF, Abosaooda M, Heidari M, Golmohammadi M, Anoush M (2023) Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: an overview and update on new developments. Fundam Clin Pharmacol 37:1050\u20131064. https:\/\/doi.org\/10.1111\/fcp.12926","journal-title":"Fundam Clin Pharmacol"},{"key":"3539_CR135","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","volume":"20","author":"WC Zhou","year":"2014","unstructured":"Zhou WC, Zhang QB, Qiao L (2014) Pathogenesis of liver cirrhosis. World J Gastroenterol 20:7312\u20137324. https:\/\/doi.org\/10.3748\/wjg.v20.i23.7312","journal-title":"World J Gastroenterol"},{"key":"3539_CR136","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.2147\/DDDT.S179227","volume":"12","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Wang HD, Zhou XM, Fang J, Zhu L, Ding K (2018) N-acetylcysteine amide provides neuroprotection via Nrf2-ARE pathway in a mouse model of traumatic brain injury. Drug Des Devel Ther 12:4117\u20134127. https:\/\/doi.org\/10.2147\/DDDT.S179227","journal-title":"Drug Des Devel Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03539-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03539-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03539-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:49:02Z","timestamp":1742280542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03539-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3539"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03539-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}